Table 7. Factors associated with fever by univariate analyses.
| Items | Sessions with fever (n = 35) | Sessions without fever (n = 297) | P-value | |
|---|---|---|---|---|
| Patient characteristics | ||||
| Elevated body temperature before CART (≥ 37°C) | 51.4% | 33.3% | 0.034 | |
| White blood cell counts [×103/μL] | 6.1 ± 3.3 | 7.4 ± 4.6 | 0.044 | |
| eGFR<30mL/min/1.73m2 [%] | 3.0% | 10.2% | 0.181 | |
| Concomitant medications | ||||
| Diuretics | 40.0% | 52.5% | 0.161 | |
| Anticancer drugs | 31.4% | 14.5% | 0.010 | |
| Steroids/NSAIDs | 8.6% | 46.8% | < 0.001 | |
| Properties of original ascites | ||||
| Transudative ascites | 44.4% | 52.5% | 0.425 | |
| Bloody ascites | 28.6% | 24.6% | 0.606 | |
| Chylous ascites | 8.6% | 9.6% | 1.000 | |
| Fibrin clot formation | 14.3% | 12.5% | 0.764 | |
| Heparin addition in bags | 8.6% | 26.9% | 0.018 | |
| Filtration-concentration condition | ||||
| Pump use as the driving force | 85.7% | 76.4% | 0.214 | |
| Inside-out as direction of filtration | 91.4% | 89.6% | 0.731 | |
| Processing speed [g/min] | 47.9 ± 33.8 | 46.9 ± 27.5 | 0.846 | |
| Duration of processing [min] | 95.3 ± 48.9 | 93.8 ± 54.2 | 0.879 | |
| Concentration ratio | 8.6 ± 4.5 | 9.1 ± 4.8 | 0.575 | |
| Reinfusion condition | ||||
| Amount of reinfused ascites [g] | 508 ± 482 | 500 ± 308 | 0.926 | |
| Total protein concentration for reinfusion [g/dL] | 12.9 ± 4.5 | 13.4 ± 6.6 | 0.429 | |
| Amount of reinfused protein [g] | 67.2 ± 44.4 | 67.8 ± 41.5 | 0.943 | |
| Reinfusion speed [g/hr] | 111.9 ± 41.9 | 107.9 ± 64.4 | 0.629 | |
NSAIDs: non-steroidal anti-inflammatory drugs. eGFR: estimated glomerular filtration rate.